Kumar Avishek

423 total citations
14 papers, 278 citations indexed

About

Kumar Avishek is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology. According to data from OpenAlex, Kumar Avishek has authored 14 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 10 papers in Epidemiology and 4 papers in Parasitology. Recurrent topics in Kumar Avishek's work include Research on Leishmaniasis Studies (14 papers), Trypanosoma species research and implications (10 papers) and Parasites and Host Interactions (4 papers). Kumar Avishek is often cited by papers focused on Research on Leishmaniasis Studies (14 papers), Trypanosoma species research and implications (10 papers) and Parasites and Host Interactions (4 papers). Kumar Avishek collaborates with scholars based in India, United States and France. Kumar Avishek's co-authors include Poonam Salotra, Sandeep Verma, V. Ramesh, V. Ramesh, Hira L. Nakhasi, Angamuthu Selvapandiyan, Sreenivas Gannavaram, Ranadhir Dey, Himanshu Kaushal and Ruchi Singh and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and PLoS neglected tropical diseases.

In The Last Decade

Kumar Avishek

13 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumar Avishek India 8 251 151 60 32 21 14 278
Beatriz Julieta Celeste Brazil 11 284 1.1× 209 1.4× 55 0.9× 43 1.3× 15 0.7× 30 315
Rômulo Pessoa-e-Silva Brazil 9 276 1.1× 164 1.1× 75 1.3× 54 1.7× 20 1.0× 21 345
Breanna M. Scorza United States 8 268 1.1× 143 0.9× 60 1.0× 58 1.8× 43 2.0× 20 323
Lays Adrianne Mendonça Trajano-Silva Brazil 7 216 0.9× 131 0.9× 58 1.0× 50 1.6× 16 0.8× 13 273
Marliane Batista Campos Brazil 13 332 1.3× 238 1.6× 85 1.4× 30 0.9× 15 0.7× 38 363
Rayana Carla Silva de Morais Brazil 9 305 1.2× 185 1.2× 85 1.4× 50 1.6× 18 0.9× 19 356
Nahid Maspi Iran 8 266 1.1× 133 0.9× 53 0.9× 82 2.6× 34 1.6× 16 335
Ana Victoria Ibarra‐Meneses Spain 12 253 1.0× 178 1.2× 61 1.0× 24 0.8× 33 1.6× 27 297
Anette Chrusciak Talhari Brazil 9 296 1.2× 185 1.2× 36 0.6× 35 1.1× 15 0.7× 10 352
Shyam Sundar India 8 356 1.4× 210 1.4× 85 1.4× 42 1.3× 13 0.6× 11 388

Countries citing papers authored by Kumar Avishek

Since Specialization
Citations

This map shows the geographic impact of Kumar Avishek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Avishek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Avishek more than expected).

Fields of papers citing papers by Kumar Avishek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar Avishek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Avishek. The network helps show where Kumar Avishek may publish in the future.

Co-authorship network of co-authors of Kumar Avishek

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar Avishek. A scholar is included among the top collaborators of Kumar Avishek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar Avishek. Kumar Avishek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Avishek, Kumar, Kavita Vats, A. Singh, et al.. (2024). Manufacturing and preclinical toxicity of GLP grade gene deleted attenuated Leishmania donovani parasite vaccine. Scientific Reports. 14(1). 14636–14636. 1 indexed citations
2.
Ramesh, V., Kumar Avishek, Sushruta Kathuria, et al.. (2023). Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India. Indian Journal of Dermatology Venereology and Leprology. 90(1). 78–84. 1 indexed citations
3.
Avishek, Kumar, et al.. (2022). An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient. Acta Parasitologica. 67(2). 687–696. 1 indexed citations
4.
Avishek, Kumar, Dibyabhaba Pradhan, Sreenivas Gannavaram, et al.. (2018). A Leishmania-specific gene upregulated at the amastigote stage is crucial for parasite survival. Parasitology Research. 117(10). 3215–3228. 3 indexed citations
5.
Gannavaram, Sreenivas, Parna Bhattacharya, Ranadhir Dey, et al.. (2016). Methods to Evaluate the Preclinical Safety and Immunogenicity of Genetically Modified Live-Attenuated Leishmania Parasite Vaccines. Methods in molecular biology. 1403. 623–638.
6.
Avishek, Kumar, Himanshu Kaushal, Sreenivas Gannavaram, et al.. (2016). Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs. Scientific Reports. 6(1). 33059–33059. 29 indexed citations
7.
Kaushal, Himanshu, Rachel Bras‐Gonçalves, Kumar Avishek, et al.. (2016). Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India. Clinical & Experimental Immunology. 185(1). 50–60. 16 indexed citations
8.
Ramesh, V., Ruchi Singh, Kumar Avishek, et al.. (2015). Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India. PLoS neglected tropical diseases. 9(10). e0004093–e0004093. 54 indexed citations
9.
Avishek, Kumar, et al.. (2014). Combination Therapy with Amphotericin-B and Miltefosine for Post-kala-azar Dermal Leishmaniasis: A Preliminary Report. Acta Dermato Venereologica. 94(2). 242–243. 12 indexed citations
10.
Gannavaram, Sreenivas, Ranadhir Dey, Kumar Avishek, et al.. (2014). Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications. Frontiers in Immunology. 5. 241–241. 40 indexed citations
11.
Ramesh, V., Kumar Avishek, & Poonam Salotra. (2014). Post‐kala‐azar dermal leishmaniasis in HIV‐coinfected individuals: problems in diagnosis and treatment. International Journal of Dermatology. 54(1). 116–120. 2 indexed citations
12.
Verma, Sandeep, et al.. (2013). Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis. Diagnostic Microbiology and Infectious Disease. 75(4). 390–395. 57 indexed citations
13.
Katara, Gajendra K., Rajesh Kumar, Kumar Avishek, et al.. (2013). Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica. BMC Immunology. 14(1). 52–52. 33 indexed citations
14.
Verma, Sandeep, et al.. (2012). Reliable diagnosis of post‐kala‐azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures. Tropical Medicine & International Health. 18(3). 268–275. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026